research Alopecia Universalis: An Extremely Rare but Probable Adverse Effect of Adalimumab
Adalimumab can cause complete hair loss in rare cases.
Search
forProducts matching "topical agents"
Tracking 4 products like 113 FOLLICS FR16, 115 Ketocolost shampoo, 173 Nizoral (Ketoconazole) Anti-Dandruff Treatment 2% and 308 Melamet from by companies like Minoxidil Express, Inhouse Pharmacy and Realiable Pharmacy. View all 4 products »
Sort by
Research
690-720 / 1000+ results 
research Literature Review on Atopic Dermatitis and Related Studies
Atopic dermatitis may have genetic causes and can be treated with pharmacologic methods, glycerin creams, and controlling Staphylococcus aureus colonization.
research E.L.F. Square Waves: A New Therapy for Androgenetic Alopecia?
New therapy helps treat hair loss.
research E.L.F. Square Waves: A New Therapy for Androgenetic Alopecia?
New therapy helps treat hair loss.
research Hypertrichosis and Hyperpigmentation in the Periocular Area Associated with Travoprost Treatment
Using travoprost for glaucoma may cause extra hair growth and darker skin around the eyes, but these effects can reverse after stopping the drug.
research Platelet-Rich Plasma in the Treatment of Alopecia Areata: A Retrospective Evaluation of 17 Patients
PRP treatment may help with alopecia areata, especially in newer cases.
research Demodex Mites
Demodex mites can cause skin issues, especially in people with weak immune systems.
research IL-36γ Drives Skin Toxicity Induced by EGFR/MEK Inhibition and Commensal Cutibacterium Acnes
A protein called IL-36γ causes skin side effects from certain cancer treatments when combined with a common skin bacteria.
research Comparative Efficacy Study of Combination of Oral Methotrexate and Prednisolone Versus Oral Methotrexate in Patients with Lichen Planopilaris
Methotrexate alone is as effective and safe as combining it with prednisolone for treating Lichen planopilaris.
research Spontaneous Complete Resolution of Alopecia Totalis Post SARS-CoV-2 Infection
A woman's complete hair loss condition improved after recovering from COVID-19.
research Safety and Efficacy of ALRV5XR in Men with Androgenetic Alopecia: A Randomised, Double-Blinded, Placebo-Controlled Clinical Trial
ALRV5XR effectively increases hair density in men with androgenetic alopecia without adverse effects.
research Oral Isotretinoin Therapy and Milia Formation in Patients with Acne Vulgaris: A Prospective Study
Oral isotretinoin does not cause milia in acne patients.
research Cannabinoid Signaling in the Skin: Therapeutic Potential of the Cutaneous Cannabinoid System
Cannabinoids may help treat various skin conditions.
research Common Skin Disorders in Pediatric Skin of Color
Children with darker skin tones can have specific skin conditions that need tailored treatments.
research Taiwanese Dermatological Association Consensus for the Prevention and Management of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor-Related Skin Toxicities
The guidelines help doctors manage skin problems from certain cancer treatments to improve patients' lives.
research Hair Growth Effect of TS-SCLF from Schisandra Chinensis Extract Fermented with Lactobacillus Plantarum
TS-SCLF from fermented Schisandra chinensis may promote hair growth and improve hair quality.
research Lipid Analysis of Follicular Casts from Cyanoacrylate Strips as a New Method for Studying Therapeutic Effects of Anti-Acne Agents
The method effectively measures lipid changes and drug effects on skin follicles.
research Androgenetic Alopecia
Androgenetic alopecia is a common hair loss condition caused by testosterone effects on hair follicles, leading to thinner, shorter, and less pigmented hair, diagnosed using scalp dermoscopy and treated with topical minoxidil, antiandrogen agents, and 5-alpha reductase inhibitors.
research Topical Corticosteroids Induced Hyperpigmentation: A Case Report
Misusing topical corticosteroids can cause skin darkening and other side effects.
research Expanding Research and Development of Novel Agents for the Treatment and Prevention of Chemotherapy-Induced Alopecia
No FDA-approved treatments for chemotherapy-induced hair loss existed in 2006; more research was needed.
research Retinoids: New Uses and New Synthetic Agents
New retinoids are effective for various skin conditions and are being developed to have fewer side effects.
research Reporting on Adverse Clinical Events
The FDA warned about safety issues with remdesivir and tofacitinib, finasteride is linked to suicidality, potent topical corticosteroids increase osteoporosis risk, henna can cause hemolysis in G6PD deficiency, chemotherapeutic agents can cause adverse reactions, drug interactions are common in cancer patients, ketamine can reduce at-risk drinking, high dose of anticholinergics increases dementia risk in Parkinson's patients, and prenatal exposure to second-generation antipsychotics increases pregnancy complications.
research Adverse Cutaneous Reactions to Chemotherapeutic Agents and Cytokine Therapy
Chemotherapy and cytokine therapy can cause various skin reactions, including hair loss and hypersensitivity.
research Topical Finasteride Therapy in Hirsutism
Topical finasteride may help treat facial hirsutism in women.
research Topical Immunotherapies
Some treatments that modify the immune system might help with certain types of hair loss but haven't been explored for common hair loss alone.
research Common Topical Medications
The document concludes that various topical medications are effective for skin conditions but often cause skin irritation as a side effect.
research Chemical Agents and Peptides Affect Hair Growth
Certain chemicals and peptides can promote hair growth or prevent baldness.
research Influence of Depigmenting Chemical Agents on Hair and Skin Color in Yellow (Pheomelanic) and Black (Eumelanic) Mice
Certain chemicals cause hair graying in black mice but not yellow mice.
research Chapter 20: Advances in Dermatological Treatments
New treatments for skin diseases are more effective and patient-friendly, but many still lack a cure.
research Topical Application of Anti-Cancer Drug Bortezomib Stimulates Proliferation of Follicular Cells and Induces Expression of Hair Keratins via GATA-3 Transcription Factor
Applying the anti-cancer drug Bortezomib to skin can promote hair growth and increase hair proteins through the GATA-3 factor.